We are live on ! Find out more
LWCFA

Loring Wolcott & Coolidge Fiduciary Advisors Portfolio holdings

AUM $10.3B
1-Year Est. Return 3.26%
This Fund
S&P 500
This Quarter Est. Return
+13.28%
1 Year Est. Return
+3.26%
3 Year Est. Return
+43.63%
5 Year Est. Return
+56.22%
10 Year Est. Return
+342.64%
AUM
$8.93B
AUM Growth
+$966M
Cap. Flow
+$40.1M
Cap. Flow %
0.45%
Top 10 Hldgs %
43.01%
Holding
808
New
213
Increased
177
Reduced
136
Closed
24

Top Buys

Rank Stock Value
1
PYPL icon
PayPal
PYPL
+$37.6M
2
COST icon
Costco
COST
+$18.3M
3
NOW icon
ServiceNow
NOW
+$16M
4
EW icon
Edwards Lifesciences
EW
+$12.1M
5
TMO icon
Thermo Fisher Scientific
TMO
+$10.5M

Sector Composition

Rank Sector Weight
1 Technology 34.83%
2 Healthcare 18.09%
3 Financials 11.74%
4 Consumer Discretionary 11.38%
5 Communication Services 7.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PCRX icon
676
Pacira BioSciences
PCRX
$945M
$6K ﹤0.01%
+95
New +$5.56K
RIG icon
677
Transocean
RIG
$6.37B
$6K ﹤0.01%
2,592
RMAX icon
678
RE/MAX Holdings
RMAX
$263M
$6K ﹤0.01%
+165
New +$5.62K
SHV icon
679
iShares 0-1 Year Treasury Bond ETF
SHV
$20.6B
$6K ﹤0.01%
55
VLO icon
680
Valero Energy
VLO
$95.1B
$6K ﹤0.01%
109
+60
+122% +$2.94K
CCF
681
DELISTED
Chase Corporation
CCF
$6K ﹤0.01%
+56
New +$5.87K
CCXI
682
DELISTED
ChemoCentryx, Inc.
CCXI
$6K ﹤0.01%
+99
New +$5.67K
BLKB icon
683
Blackbaud
BLKB
$2.03B
$5K ﹤0.01%
+88
New +$4.89K
CMA
684
DELISTED
Comerica
CMA
$5K ﹤0.01%
+83
New +$4.05K
EBS icon
685
Emergent Biosolutions
EBS
$233M
$5K ﹤0.01%
+61
New +$5.6K
IPG
686
DELISTED
Interpublic Group of Companies
IPG
$5K ﹤0.01%
+230
New +$4.82K
MGNX icon
687
MacroGenics
MGNX
$256M
$5K ﹤0.01%
213
NDAQ icon
688
Nasdaq
NDAQ
$53.5B
$5K ﹤0.01%
117
+48
+70% +$2.03K
PARA
689
DELISTED
Paramount Global Class B
PARA
$5K ﹤0.01%
140
+86
+159% +$2.76K
PIPR icon
690
Piper Sandler
PIPR
$5.34B
$5K ﹤0.01%
212
+32
+18% +$726
SCHL icon
691
Scholastic
SCHL
$792M
$5K ﹤0.01%
+219
New +$5.04K
STR
692
DELISTED
Sitio Royalties
STR
$5K ﹤0.01%
+434
New +$4.4K
UNIT
693
Uniti Group
UNIT
$2.31B
$5K ﹤0.01%
397
WING icon
694
Wingstop
WING
$3.05B
$5K ﹤0.01%
+34
New +$4.44K
TVRD
695
Tvardi Therapeutics
TVRD
$22.1M
$5K ﹤0.01%
+8
New +$4.19K
HRC
696
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$5K ﹤0.01%
50
+26
+108% +$2.43K
BPYU
697
DELISTED
Brookfield Property REIT Inc. Class A Common Stock
BPYU
$5K ﹤0.01%
+320
New +$4.87K
AJG icon
698
Arthur J. Gallagher & Co
AJG
$65.5B
$4K ﹤0.01%
+31
New +$3.53K
AMP icon
699
Ameriprise Financial
AMP
$49.9B
$4K ﹤0.01%
19
AON icon
700
Aon
AON
$74.7B
$4K ﹤0.01%
+18
New +$3.67K

Similar funds

Loring Wolcott & Coolidge Fiduciary Advisors's Q4 2020 Portfolio in Review

As of Q4 2020, Loring Wolcott & Coolidge Fiduciary Advisors held 808 positions worth $8.93B, up 12% from $7.97B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Loring Wolcott & Coolidge Fiduciary Advisors's Q4 2020 filing shows 213 new, 177 increased, 136 reduced and 24 closed positions. Its largest new stake was Vontier: 38,519 shares worth $1.29M. The largest sale was Automatic Data Processing, an estimated $26.2M.

By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 34% a quarter earlier, followed by Healthcare and Financials.

  • Loring Wolcott & Coolidge Fiduciary Advisors's largest Q4 2020 buy was Vontier: 38,519 shares worth $1.29M.
  • Loring Wolcott & Coolidge Fiduciary Advisors added most to PayPal in Q4 2020, an estimated $37.6M increase.
  • Loring Wolcott & Coolidge Fiduciary Advisors's biggest Q4 2020 reduction was Automatic Data Processing, cutting an estimated $26.2M.
  • Loring Wolcott & Coolidge Fiduciary Advisors fully exited iShares Russell 1000 ETF in Q4 2020, selling an estimated $2.48M.
  • Loring Wolcott & Coolidge Fiduciary Advisors's ten largest holdings make up 43% of its $8.93B portfolio in Q4 2020.
  • Loring Wolcott & Coolidge Fiduciary Advisors opened 213 new positions and closed 24 in Q4 2020.
  • Loring Wolcott & Coolidge Fiduciary Advisors's portfolio value rose 12% quarter-over-quarter to $8.93B.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q4 2020, filed 14 Jan 2021.